- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: TAS-115
Total 6422 results
-
Placon TherapeuticsUnknownBreast Neoplasms | Prostatic Neoplasms | Pancreatic Neoplasms | Ovarian NeoplasmsUnited States
-
M.D. Anderson Cancer CenterDirect TherapeuticsCompletedGlioma | Brain NeoplasmsUnited States
-
Oriental Neurosurgery Evidence-Based-Study TeamUnknownParkinson DiseaseChina
-
Chong Kun Dang PharmaceuticalUnknown
-
Taiho Pharmaceutical Co., Ltd.RecruitingGastrointestinal Stromal TumorsTaiwan, Japan, China, Australia, Singapore
-
VA Office of Research and DevelopmentCompleted
-
Auris Medical AGCompleted
-
MallinckrodtTerminated
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Highlight TherapeuticsTerminatedAdvanced Hepatocellular Carcinoma | BCLC Stage B Hepatocellular Carcinoma | BCLC Stage C Hepatocellular Carcinoma | Refractory Hepatocellular CarcinomaUnited States
-
TakedaTakeda Development Center Americas, Inc.TerminatedCrohn DiseaseUnited States, Germany, Austria, France, United Kingdom
-
Johns Hopkins UniversityTerminatedDiabetic Retinopathy | Stargardt Disease | Macular Degeneration (Age Related)United States
-
Neurocrine BiosciencesTakedaCompletedHealthy VolunteersUnited States
-
Millennium Pharmaceuticals, Inc.Terminated
-
PfizerTerminatedCachexiaUnited States
-
Providence Health & ServicesTaiho OncologyCompletedRectal CancerUnited States
-
University of California, Los AngelesActive, not recruiting
-
Millennium Pharmaceuticals, Inc.CompletedA Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic HypersomniaIdiopathic HypersomniaUnited States, Japan
-
TakedaWithdrawnHealthy VolunteersUnited States
-
Neurocrine BiosciencesTakedaCompletedFriedreich AtaxiaUnited States
-
Tianjin Nankai HospitalTianjin First Central Hospital; Anyang People's Hospital; Tianjin Beichen HospitalCompleted
-
TakedaCompletedJapanese Healthy Adult Male ParticipantsJapan
-
TakedaCompletedHealthy ParticipantsUnited States
-
TakedaCompletedJapanese Healthy Adult MaleJapan
-
TakedaCompletedHealthy ParticipantsUnited States
-
TakedaCompleted
-
Noema Pharma AGCompletedChildhood-Onset Fluency DisorderUnited States, Australia
-
Walter Reed Army Institute of Research (WRAIR)National Institute of Mental Health (NIMH); National Intrepid Center of ExcellenceRecruiting
-
NovaRock Biotherapeutics, LtdNot yet recruitingAdvanced Solid TumorsChina
-
University of Alabama at BirminghamNot yet recruiting
-
4D Molecular TherapeuticsActive, not recruitingChoroideremiaUnited States
-
ORIC PharmaceuticalsCompleted
-
University of PennsylvaniaTerminatedMild Cognitive ImpairmentUnited States
-
REGENXBIO Inc.Active, not recruitingHurler Syndrome | Hurler-Scheie Syndrome | Mucopolysaccharidosis Type I (MPS I)United States, Brazil, Israel
-
Dongkook Pharmaceutical Co., Ltd.Active, not recruiting
-
Promontory Therapeutics Inc.CompletedMultiple MyelomaUnited States
-
University of PennsylvaniaUniversity of Miami; Biogen; University of KansasTerminated
-
SecuraBioCompletedHepatic ImpairmentUnited States
-
argenxCompletedBioavailability StudyNetherlands
-
Fusion Pharma LLCData Matrix Solutions; OCT Rus, LLC; Skolkovo Innovation CenterUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Chronic Myeloid LeukemiaRussian Federation
-
Jazz PharmaceuticalsCompletedObstructive Sleep ApneaUnited States, Finland, Germany, France, Sweden
-
University of Illinois at ChicagoRush University Medical Center; American Society for Parenteral and Enteral...CompletedSystemic Inflammatory Response Syndrome | Oxidative Stress | Acute Respiratory Distress Syndrome | Euthyroid Sick SyndromesUnited States
-
Johns Hopkins UniversityNational Institute on Aging (NIA)CompletedAlzheimer's DiseaseUnited States
-
Draeger Medical Systems, Inc.CompletedHyperbilirubinemia | Neonatal JaundiceCanada
-
Synektik S.A.European CommissionCompleted
-
Kissei Pharmaceutical Co., Ltd.Completed
-
BioMarin PharmaceuticalApproved for marketingMorquio A Syndrome | MPS IVA | Mucopolysaccharidosis IVAUnited States, Puerto Rico
-
Wyeth is now a wholly owned subsidiary of PfizerEmergent Product Development Seattle LLCTerminatedSystemic Lupus ErythematosusUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted